| Website | exagen.com |
| Category | BioTech |
| Phone | 505-272-7966 |
| Info@exagen.com | |
| Employees |
| TOTAL | $12.3M |
| FUNDING TOTAL | $12.3M |
| Series B, 6/05 Tullis-Dickerson vSpring Capital Epic Ventures | $7M |
| Venture Round, 9/12 Tullis Health Investors Cottonwood Technology Fund Epic Ventures Mesa Verde Venture Partners Sun Mountain Capital | $5.3M |
Exagen Diagnostics is a patient focused, discovery driven CLIA registered molecular diagnostics laboratory with a growing menu of proprietary, internally developed genomic tests. Exagen is the emerging leader in laboratory-discovered and developed genomic tests specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management.
